Michael Hinds

740 total citations
18 papers, 641 citations indexed

About

Michael Hinds is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Michael Hinds has authored 18 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Public Health, Environmental and Occupational Health and 5 papers in Oncology. Recurrent topics in Michael Hinds's work include Cancer therapeutics and mechanisms (14 papers), Acute Lymphoblastic Leukemia research (7 papers) and Lung Cancer Research Studies (4 papers). Michael Hinds is often cited by papers focused on Cancer therapeutics and mechanisms (14 papers), Acute Lymphoblastic Leukemia research (7 papers) and Lung Cancer Research Studies (4 papers). Michael Hinds collaborates with scholars based in United States and United Kingdom. Michael Hinds's co-authors include Janice Mayes, R J Meyer, Leonard A. Zwelling, Diana Chan, Elizabeth Altschuler, Lynn Silberman, Karl Deisseroth, Mark Blick, Fred D. Ledley and Ruud Jansen and has published in prestigious journals such as Journal of Biological Chemistry, JNCI Journal of the National Cancer Institute and Biochemistry.

In The Last Decade

Michael Hinds

18 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Hinds United States	10	526	267	91	84	83	18	641
Michael F. Belcourt United States	17	719 1.4×	107 0.4×	147 1.6×	93 1.1×	82 1.0×	25	932
Anne-Marie de Recondo France	12	475 0.9×	92 0.3×	52 0.6×	41 0.5×	36 0.4×	30	573
Anna Valenti Italy	18	627 1.2×	45 0.2×	125 1.4×	30 0.4×	56 0.7×	42	753
Anikó Hevér Hungary	12	226 0.4×	114 0.4×	38 0.4×	14 0.2×	60 0.7×	19	591
U. Schomburg Germany	6	404 0.8×	64 0.2×	78 0.9×	28 0.3×	51 0.6×	6	474
Yasunori Funayama Japan	12	296 0.6×	133 0.5×	16 0.2×	24 0.3×	100 1.2×	26	457
Kay Osborn United Kingdom	9	358 0.7×	280 1.0×	15 0.2×	23 0.3×	44 0.5×	10	534
Cintia Cruz Argentina	6	700 1.3×	39 0.1×	237 2.6×	7 0.1×	9 0.1×	16	776
Kae Yanase Japan	6	174 0.3×	190 0.7×	23 0.3×	11 0.1×	29 0.3×	8	337
Yingqing Mao China	12	292 0.6×	34 0.1×	15 0.2×	16 0.2×	82 1.0×	19	492

Countries citing papers authored by Michael Hinds

Since Specialization

Citations

This map shows the geographic impact of Michael Hinds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hinds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hinds more than expected).

Fields of papers citing papers by Michael Hinds

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Hinds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hinds. The network helps show where Michael Hinds may publish in the future.

Co-authorship network of co-authors of Michael Hinds

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Hinds. A scholar is included among the top collaborators of Michael Hinds based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Hinds. Michael Hinds is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Ellis, Amy, Elizabeth Altschuler, Elise S. Bales, et al.. (1994). Phorbol regulation of topoisomerases I and II in human leukemia cells. Biochemical Pharmacology. 47(2). 387–396. 4 indexed citations

Mayes, Janice, et al.. (1993). Further characterization of an amsacrine-resistant line of HL-60 human leukemia cells and its topoisomerase II. Biochemical Pharmacology. 46(4). 699–707. 8 indexed citations

Ellis, Amy, Roderick T. Bunch, Joyce K. Randolph, et al.. (1992). Components of intrinsic drug resistance in the rat hepatoma. Biochemical Pharmacology. 43(2). 331–342. 8 indexed citations

Mitchell, Michael, et al.. (1992). Relative activity of structural analogues of amsacrine against human leukemia cell lines containing amsacrine-sensitive or -resistant forms of topoisomerase II: use of computer simulations in new drug development.. PubMed. 52(1). 209–17. 22 indexed citations

Zwelling, Leonard A., Diana Chan, Elizabeth Altschuler, et al.. (1991). Effect of bryostatin 1 on drug-induced, topoisomerase II-mediated DNA cleavage and topoisomerase 11 gene expression in human leukemia cells. Biochemical Pharmacology. 41(5). 829–832. 1 indexed citations

Whelan, Richard D. H., et al.. (1991). A lack of detectable modification of topoisomerase II activity in a series of human tumor cell lines expressing only low levels of etoposide resistance. International Journal of Cancer. 47(6). 899–902. 9 indexed citations

Zwelling, Leonard A., Elizabeth Altschuler, Janice Mayes, Michael Hinds, & Diana Chan. (1991). The effect of staurosporine on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells. Cancer Chemotherapy and Pharmacology. 29(1). 48–52. 4 indexed citations

Zwelling, Leonard A., Michael Hinds, Diana Chan, et al.. (1991). Cross-resistance of an amsacrine-resistant human leukemia line to topoisomerase II reactive DNA intercalating agents. Evidence for two topoisomerase II directed drug actions. Biochemistry. 30(16). 4048–4055. 37 indexed citations

Hinds, Michael, Karl Deisseroth, Janice Mayes, et al.. (1991). Identification of a point mutation in the topoisomerase II gene from a human leukemia cell line containing an amsacrine-resistant form of topoisomerase II.. PubMed. 51(17). 4729–31. 126 indexed citations

10.

Zwelling, Leonard A., Janice Mayes, Karl Deisseroth, et al.. (1990). A Restriction Fragment Length Polymorphism for Human Topoisomerase II: Possible Relationship to Drug-Resistance. PubMed. 2(11). 357–361. 8 indexed citations

11.

Zwelling, Leonard A., Marilyn L. Slovak, J. H. Doroshow, et al.. (1990). HT1080/DR4: A P-Glycoprotein-Negative Human Fibrosarcoma Cell Line Exhibiting Resistance to Topoisomerase II-Reactive Drugs Despite the Presence of a Drug-Sensitive Topoisomerase II. JNCI Journal of the National Cancer Institute. 82(19). 1553–1561. 48 indexed citations

12.

Zwelling, Leonard A., Michael Hinds, Diana Chan, et al.. (1990). Phorbol ester effects on topoisomerase II activity and gene expression in HL-60 human leukemia cells with different proclivities toward monocytoid differentiation.. PubMed. 50(22). 7116–22. 33 indexed citations

13.

Zwelling, Leonard A., Michael Hinds, Diana Chan, et al.. (1989). Characterization of an Amsacrine-resistant Line of Human Leukemia Cells. Journal of Biological Chemistry. 264(28). 16411–16420. 159 indexed citations

14.

Zwelling, Leonard A., Diana Chan, Michael Hinds, Lynn Silberman, & Janice Mayes. (1988). Anion-dependent modulations of DNA topoisomerase II-mediated reactions in potassium-containing solutions. Biochemical and Biophysical Research Communications. 152(2). 808–817. 8 indexed citations

15.

Zwelling, Leonard A., Diana Chan, Michael Hinds, et al.. (1988). Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells.. PubMed. 48(23). 6625–33. 32 indexed citations

16.

Meyer, R J & Michael Hinds. (1982). Multiple mechanisms for expression of incompatibility by broad-host-range plasmid RK2. Journal of Bacteriology. 152(3). 1078–1090. 44 indexed citations

17.

Meyer, R J, et al.. (1982). Broad-host-range IncP-4 plasmid R1162: effects of deletions and insertions on plasmid maintenance and host range. Journal of Bacteriology. 152(1). 140–150. 37 indexed citations

18.

Meyer, R J, Michael Hinds, & Michael A. Brasch. (1982). Properties of R1162, a broad-host-range, high-copy-number plasmid. Journal of Bacteriology. 150(2). 552–562. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact